| Line item | 2025-12-31 FY | 2024-12-31 FY | 2023-12-31 FY | 2022-12-31 FY | 2021-12-31 FY | 2021-03-31 FY |
|---|---|---|---|---|---|---|
| Revenue | $729.47M | $731.78M | $736.13M | $675.70M | $361.93M | $57.85M |
| Cost of Revenue | – | – | – | – | – | – |
| Gross Profit | – | – | – | – | – | – |
| Operating Expenses | – | – | – | – | – | – |
| R&D | – | – | – | – | – | – |
| SG&A | $32.82M | $31.89M | $32.53M | $30.77M | $29.43M | – |
| Operating Income | $65.69M | $103.49M | $58.79M | $67.78M | -$33.27M | – |
| Interest Expense | – | – | $86.80M | $65.58M | $43.37M | – |
| Tax Expense | $842.00K | -$8.74M | $2.80M | $3.61M | $1.47M | – |
| Net Income | -$11.68M | $38.89M | -$28.12M | $1.22M | -$65.57M | -$31.36M |
| EPS (basic) | -0.2200 | 0.2300 | -0.2700 | -0.1600 | -0.8000 | -0.3400 |
| EPS (diluted) | -0.2200 | 0.2200 | -0.2700 | -0.1600 | -0.8000 | -0.3400 |
| Shares (diluted) | $106.85M | $132.37M | $105.55M | $105.14M | $104.47M | – |